John Fieldly

CEO John Fieldly buys 8,475 shares of CELH at $29.36 amid -55.5% decline from 52-week high

John Fieldly, Chief Executive Officer, purchased 8,475 shares on 2026-05-22 at $29.36, increasing his holdings to 937,540 shares. The purchase occurs as CELH trades -55.5% below its 52-week high of $66.74 and has declined -41.4% over the past 90 days. Fieldly's cross-ticker track record shows a 50.00% well-timed rate on 10 prior sells with +6.4% average 90-day return, indicating mixed timing acumen. His same-ticker history at CELH shows 5 prior sales, 2 of which were well-timed at the 90-day mark; notably, 3 of those 5 sales captured gains of +14.0%, +2.9%, and +4.9% within 30 days, suggesting pattern recognition of near-term peaks. The purchase scale is modest (+0.9% of pre-transaction holdings), and the company reports strong fundamentals with +85.5% annual revenue growth and $110.1M net income on $782.6M quarterly revenue, though the P/E of 43.63 remains elevated despite current price weakness.

Celsius CEO Fieldly John sold 143.2K shares ($7.3M) at $51.18; stock now at $51.95 (+12.7% in 30d); CEO retains 895.4K shares

Fieldly John sold 143,167 shares, representing a 13.8% reduction in his CELH holdings while retaining 895.4K shares post-transaction. The sale occurred at $51.18, just below the current price of $51.95, which sits at the 52-week high. Notably, in his prior 5 trades at CELH, his 3 measurable 90-day outcomes all resulted in stock declines (-4.5%, -9.3%, and -6.0%), demonstrating a 100% well-timed rate at this ticker historically. His cross-ticker track record shows a 70.00% well-timed rate on 12 prior sells. The stock has appreciated 12.7% over 30 days and 41.3% over 90 days since this sale, suggesting this transaction did not precede a decline as his historical pattern would predict. The CEO's continued material ownership (895.4K shares) indicates ongoing alignment with shareholders despite the large disposition.

CEO John Fieldly sold 130,803 shares of CELH at $45.00 for $5,886,135.00 on 2025-06-24; stock is -27.3% from 52-week high but +22.6% in 30 days.

CEO John Fieldly sold 130,803 shares (11.2% of pre-transaction holdings) at $45.00, reducing his position from 1,169,380 to 1,038,577 shares. The sale occurs amid strong recent momentum—the stock is up 22.6% over 30 days and 35.0% over 90 days—yet remains 27.3% below its 52-week high of $62.48. His prior sales at CELH have been moderately well-timed: 3 of 4 measurable prior sales showed negative 90-day returns, aligning with his cross-ticker track record of 70.00% well-timed sells (average 90-day return −12.5%). However, context matters: this sale follows another sale just 14 days prior (2025-06-10, outcome not yet measurable), suggesting a pattern of staged liquidation rather than a single discretionary decision. Investors should track whether the recent rally continues or reverses, and monitor whether further sales materialize.

CEO Fieldly John sold 132.2K shares of CELH at $43.06 on 2025-06-10 for $5.7M; holds 1.17M post-sale, down 10.2%.

Fieldly John's sale of 132,171 shares at $43.06 represents a reduction of 10.2% of his pre-transaction holdings, a material disposition by a CEO. The stock has since declined to $41.98, trading 42.6% below its 52-week high of $73.20, suggesting this sale occurred during a period of elevated valuation. His cross-ticker track record shows a 70.00% well-timed sell rate with an average 90-day return of -12.5%, indicating a pattern of selling ahead of declines. At CELH specifically, his prior five transactions show 3 of 5 were well-timed at the 90-day mark, though recent CELH sales on 2024-09-13 and 2024-09-12 saw mixed results. The fundamental picture is clouded: revenue of $329.3M grew only 2.8% annually while the P/E of 97.63 remains stretched, suggesting the valuation environment rather than operational deterioration may be the relevant context. This sale merits monitoring given the CEO's demonstrated track record of timing exits, though the reduced equity stake warrants attention to whether broader capital allocation shifts are underway.

CEO John Fieldly sold 626,268 shares for $21,401,807.16 across two trades (Sept 12-13); post-sale holdings 1,261,069 shares (-33.2%)

CEO John Fieldly executed 2 separate sales totaling 626,268 shares for $21,401,807.16 on September 12-13 at an average price of $34.17, reducing his stake by 33.2% versus pre-transaction holdings. The blended sale price exceeds the current $33.18 price, and the CEO retains 1,261,069 shares post-transaction. At this same ticker (CELH), his prior 5 sales show mixed timing: 2 of 5 were well-timed at the 90-day mark, suggesting inconsistent predictive accuracy. The company is operationally strong with 101.6% annual revenue growth, $402.0M latest quarterly revenue, $79.8M net income, and P/E of 26.54; the material scale of this divestiture (over $21M) stands out relative to the company's $7.7B market cap and warrants examination of whether it reflects scheduled portfolio management or a shift in the CEO's position sizing at the holding.